Clinical trial
Dissecting the Role of Acetaldehyde in Oral Carcinogenesis
NCT05973656 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dissecting the Role of Acetaldehyde in Oral Carcinogenesis
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 8, 2022
- Completion date
- September 30, 2027
- Enrollment
- 170 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol-related carcinoma, fanconi anemia, oral cavity carcinoma